Annual Accounts Receivable
$41.12 M
+$10.07 M+32.41%
December 31, 2023
Summary
- As of February 12, 2025, CORT annual accounts receivable is $41.12 million, with the most recent change of +$10.07 million (+32.41%) on December 31, 2023.
- During the last 3 years, CORT annual accounts receivable has risen by +$14.93 million (+56.97%).
- CORT annual accounts receivable is now at all-time high.
Performance
CORT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$59.72 M
+$5.88 M+10.92%
September 30, 2024
Summary
- As of February 12, 2025, CORT quarterly accounts receivable is $59.72 million, with the most recent change of +$5.88 million (+10.92%) on September 30, 2024.
- Over the past year, CORT quarterly accounts receivable has dropped by -$1.80 million (-2.93%).
- CORT quarterly accounts receivable is now -2.93% below its all-time high of $61.52 million, reached on March 31, 2024.
Performance
CORT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CORT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.4% | -2.9% |
| 3 y3 years | +57.0% | +92.3% |
| 5 y5 years | +133.8% | +92.3% |
CORT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +48.9% | -2.9% | +119.7% |
| 5 y | 5-year | at high | +106.4% | -2.9% | +199.7% |
| alltime | all time | at high | -100.0% | -2.9% | -100.0% |
Corcept Therapeutics Incorporated Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $59.72 M(+10.9%) |
| Jun 2024 | - | $53.84 M(-12.5%) |
| Mar 2024 | - | $61.52 M(+49.6%) |
| Dec 2023 | $41.12 M(+32.4%) | $41.12 M(+18.8%) |
| Sep 2023 | - | $34.63 M(+6.4%) |
| Jun 2023 | - | $32.55 M(-0.0%) |
| Mar 2023 | - | $32.56 M(+4.8%) |
| Dec 2022 | $31.06 M(+12.4%) | $31.06 M(+5.6%) |
| Sep 2022 | - | $29.41 M(+4.4%) |
| Jun 2022 | - | $28.16 M(+3.6%) |
| Mar 2022 | - | $27.18 M(-1.6%) |
| Dec 2021 | $27.63 M(+5.4%) | $27.63 M(+4.2%) |
| Sep 2021 | - | $26.51 M(-4.0%) |
| Jun 2021 | - | $27.62 M(+24.4%) |
| Mar 2021 | - | $22.20 M(-15.3%) |
| Dec 2020 | $26.20 M(+31.5%) | $26.20 M(+19.3%) |
| Sep 2020 | - | $21.96 M(-3.4%) |
| Jun 2020 | - | $22.73 M(-14.8%) |
| Mar 2020 | - | $26.68 M(+33.9%) |
| Dec 2019 | $19.93 M(+13.3%) | $19.93 M(-11.1%) |
| Sep 2019 | - | $22.41 M(+13.3%) |
| Jun 2019 | - | $19.77 M(+2.9%) |
| Mar 2019 | - | $19.22 M(+9.3%) |
| Dec 2018 | $17.59 M | $17.59 M(-9.2%) |
| Sep 2018 | - | $19.36 M(-32.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $28.70 M(+66.3%) |
| Mar 2018 | - | $17.26 M(+12.8%) |
| Dec 2017 | $15.30 M(+55.2%) | $15.30 M(+28.9%) |
| Sep 2017 | - | $11.87 M(+24.9%) |
| Jun 2017 | - | $9.50 M(+3.1%) |
| Mar 2017 | - | $9.21 M(-6.6%) |
| Dec 2016 | $9.86 M(+58.5%) | $9.86 M(+19.7%) |
| Sep 2016 | - | $8.24 M(-11.5%) |
| Jun 2016 | - | $9.30 M(+37.8%) |
| Mar 2016 | - | $6.75 M(+8.5%) |
| Dec 2015 | $6.22 M(+86.6%) | $6.22 M(+4.6%) |
| Sep 2015 | - | $5.95 M(+20.1%) |
| Jun 2015 | - | $4.95 M(+15.1%) |
| Mar 2015 | - | $4.30 M(+29.0%) |
| Dec 2014 | $3.33 M(+133.5%) | $3.33 M(+21.4%) |
| Sep 2014 | - | $2.75 M(+23.4%) |
| Jun 2014 | - | $2.23 M(+15.8%) |
| Mar 2014 | - | $1.92 M(+34.6%) |
| Dec 2013 | $1.43 M(+156.4%) | $1.43 M(+40.1%) |
| Sep 2013 | - | $1.02 M(+19.2%) |
| Jun 2013 | - | $855.00 K(-25.2%) |
| Mar 2013 | - | $1.14 M(+105.2%) |
| Dec 2012 | $557.00 K(>+9900.0%) | $557.00 K(+57.3%) |
| Sep 2012 | - | $354.00 K(-0.3%) |
| Jun 2012 | - | $355.00 K(>+9900.0%) |
| Dec 2011 | $0.00 | $0.00 |
FAQ
- What is Corcept Therapeutics Incorporated annual accounts receivable?
- What is the all time high annual accounts receivable for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual accounts receivable year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly accounts receivable year-on-year change?
What is Corcept Therapeutics Incorporated annual accounts receivable?
The current annual accounts receivable of CORT is $41.12 M
What is the all time high annual accounts receivable for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual accounts receivable is $41.12 M
What is Corcept Therapeutics Incorporated annual accounts receivable year-on-year change?
Over the past year, CORT annual accounts receivable has changed by +$10.07 M (+32.41%)
What is Corcept Therapeutics Incorporated quarterly accounts receivable?
The current quarterly accounts receivable of CORT is $59.72 M
What is the all time high quarterly accounts receivable for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly accounts receivable is $61.52 M
What is Corcept Therapeutics Incorporated quarterly accounts receivable year-on-year change?
Over the past year, CORT quarterly accounts receivable has changed by -$1.80 M (-2.93%)